(Q35068200)

6 August 2017

1 reference

title

Health-related quality-of-life measurement in randomized clinical trials in breast cancer--taking stock (English)

1 reference

6 August 2017

1 reference

Pamela J Goodwin

1

0 references

Patricia Ganz

series ordinal

4

object named as

Patricia A Ganz

1 reference

6 August 2017

Jeanne T Black

2

1 reference

PubMed ID

12591983

6 August 2017

Louise J Bordeleau

series ordinal

3

1 reference

PubMed ID

12591983

6 August 2017

language of work or name

English

0 references

publication date

1 February 2003

1 reference

Journal of the National Cancer Institute

6 August 2017

1 reference

6 August 2017

95

1 reference

6 August 2017

4

1 reference

6 August 2017

263-281

1 reference

The Functional Assessment of Cancer Therapy scale: development and validation of the general measure

6 August 2017

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.4.263

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.4.263

Validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (QLQ-C30) as a measure of psychosocial function in breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.4.263

Reliability and validity of the Functional Assessment of Cancer Therapy-Breast quality-of-life instrument.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.4.263

The hospital anxiety and depression scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.4.263

Quality of life in stage II breast cancer: an instrument for clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.4.263

Quality of life after breast cancer surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.4.263

Psychosocial outcome in a randomized surgical trial for treatment of primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.4.263

Breast conservation versus mastectomy: distress sequelae as a function of choice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.4.263

A comparative study of post-operative psychosocial function in women with primary operable breast cancer randomized to breast conservation therapy or mastectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.4.263

Quality of life of early-stage breast cancer patients treated with radical mastectomy or breast-conserving procedures: results of EORTC Trial 10801. The European Organization for Research and Treatment of Cancer (EORTC), Breast Cancer Co-operative G

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.4.263

The quality of life of early breast cancer patients treated by two different radiotherapy regimens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.4.263

Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.4.263

Summary measures and statistics in the analysis of quality of life data: an example from an EORTC-NCIC-SAKK locally advanced breast cancer study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.4.263

Randomized trial of adjuvant tamoxifen and/or goserelin in premenopausal breast cancer--self-rated physiological effects and symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.4.263

Quality of life in long-term, disease-free survivors of breast cancer: a follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.4.263

Improving the quality of life during chemotherapy for advanced breast cancer. A comparison of intermittent and continuous treatment strategies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.4.263

A randomized trial of two dose levels of cyclophosphamide, methotrexate, and fluorouracil chemotherapy for patients with metastatic breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.4.263

Doxorubicin in advanced breast cancer: influence of schedule on response, survival and quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.4.263

Combination or mild single agent chemotherapy for advanced breast cancer? CMF vs epirubicin measuring quality of life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.4.263

Cyclophosphamide and fluorouracil combined with mitoxantrone versus doxorubicin for breast cancer: superiority of doxorubicin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.4.263

Maintenance treatment with medroxyprogesterone acetate in patients with advanced breast cancer responding to chemotherapy: results of a randomized trial. Essen Breast Cancer Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.4.263

Prospective randomized trial of docetaxel versus mitomycin plus vinblastine in patients with metastatic breast cancer progressing despite previous anthracycline-containing chemotherapy. 304 Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.4.263

Randomized trial to compare the efficacy and toxicity of cyclophosphamide, methotrexate and 5-fluorouracil (CMF) with methotrexate mitoxantrone (MM) in advanced carcinoma of the breast.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.4.263

Effect of megestrol acetate on quality of life in a dose-response trial in women with advanced breast cancer. The Cancer and Leukemia Group B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.4.263

Quality of life in patients with metastatic breast cancer receiving either docetaxel or sequential methotrexate and 5-fluorouracil. A multicentre randomised phase III trial by the Scandinavian breast group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.4.263

Randomised trial of paclitaxel versus doxorubicin as first-line chemotherapy for advanced breast cancer: quality of life evaluation using the EORTC QLQ-C30 and the Rotterdam symptom checklist

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.4.263

Phase III comparative study of vinorelbine combined with doxorubicin versus doxorubicin alone in disseminated metastatic/recurrent breast cancer: National Cancer Institute of Canada Clinical Trials Group Study MA8.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.4.263

Exemestane is superior to megestrol acetate after tamoxifen failure in postmenopausal women with advanced breast cancer: results of a phase III randomized double-blind trial. The Exemestane Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.4.263

Phase III, multicenter, double-blind, randomized study of letrozole, an aromatase inhibitor, for advanced breast cancer versus megestrol acetate

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.4.263

Improved control of emesis and quality of life with ondansetron in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.4.263

Prevention of adjustment disorders and anticipatory nausea secondary to adjuvant chemotherapy: a double-blind, placebo-controlled study assessing the usefulness of alprazolam.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.4.263

Oral clodronate in breast cancer patients with bone metastases: a randomized study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.4.263

Routine follow up of breast cancer in primary care: randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.4.263

Postmastectomy couple counseling: an outcome study of a structured treatment protocol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.4.263

Relaxation and imagery in the treatment of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.4.263

Randomized trial of a psychologic distress screening program after breast cancer: effects on quality of life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.4.263

The impact of a psychological intervention on quality of life in non-metastatic breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.4.263

Effects of a nursing intervention on subjective distress, side effects and quality of life of breast cancer patients receiving curative radiation therapy--a randomized study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.4.263

Can 40 seconds of compassion reduce patient anxiety?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.4.263

A randomized controlled trial of a brief psychoeducational support group for partners of early stage breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.4.263

A psychosocial group intervention for Japanese women with primary breast carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.4.263

Psychological, clinical and pathological effects of relaxation training and guided imagery during primary chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.4.263

Psychological response to long-term group therapy: a randomized trial with metastatic breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.4.263

A group cognitive behaviour therapy programme with metastatic breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.4.263

Supportive-expressive group therapy and distress in patients with metastatic breast cancer: a randomized clinical intervention trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.4.263

The effect of group psychosocial support on survival in metastatic breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.4.263

Managing menopausal symptoms in breast cancer survivors: results of a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.4.263

Effect of psychosocial treatment on survival of patients with metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.4.263

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.4.263

Missing quality of life data in cancer clinical trials: serious problems and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.4.263

Interpreting the significance of changes in health-related quality-of-life scores.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.4.263

21 January 2018

Identifiers

DOI

10.1093/JNCI/95.4.263

1 reference

6 August 2017

1 reference

PubMed ID

12591983